In CLL, malignant B cells proliferate excessively through B-cell receptor (BCR)–dependent signaling and fail to undergo apoptosis efficiently as a result of overexpression of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2). Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.